GOLDMAN SACHS GROUP INC

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol
FDMT on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
4,286,077 shares
Security Ownership %
7.5%
Shares, Excluding Options vs Price
Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

09 Feb 2026 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,286,077 shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 7.5% ownership of the company. In their previous filing dated 10 Feb 2025, GOLDMAN SACHS GROUP INC had reported owning 4,423,435 shares, indicating a decrease of +3.1%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.